Long-term efficacy and updated survival outcomes of sintilimab plus anlotinib in patients with PD-L1-positive recurrent or metastatic cervical cancer. - Liu, Jing; Lan, Chunyan; Liu, Tongyu; Liu, Qin; Chang, Lele; Zang, Lele; Zhu, Fei; Zhu, Mingxuan; Zhang, Huiqi; Kang, Yaxin; Wang, Yuqin; Lu, Huaiwu; et al. (BMC Medicine, 2025)